University Health Network, Toronto General Hospital, Multi-Organ Transplant
Welcome,         Profile    Billing    Logout  
 2 Trials 
1 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kumar, Deepali
RSV OA=ADJ-023, NCT05921903: A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

Active, not recruiting
2
387
Europe, Canada, Japan, US, RoW
RSVPreF3 OA Investigational Vaccine
GlaxoSmithKline
Respiratory Syncytial Virus Infections
07/24
06/25
Humar, Atul
No trials found
Kumar, Deeplai
No trials found

Download Options